Search results for "neuropsychological assessment"

showing 10 items of 67 documents

Validation of a New Cognitive Screening Method for Stroke Patients

2019

Objective. Two million adults under fifty years of age have a cerebral stroke every year worldwide. Neuropsychological assessment is the best way to identify poststroke cognitive dysfunction, but it is often time-consuming and can be tiring for the patient, and hospitals vary in their availability of neuropsychological expertise. A valid and reliable cognitive screening method could be advantageous in identifying patients who need comprehensive neuropsychological examination. Our purpose in this study was to validate a newly developed cognitive screening method as an identifier of cognitive dysfunction after stroke in working-aged patients. Methods. We analyzed new cognitive screening metho…

MaleNeuropsychological TestsaivohalvauspotilaatCognition0302 clinical medicineMass ScreeningMedicine030212 general & internal medicineNeuropsychological assessmentCognitive declineStrokevalidationmedicine.diagnostic_testNeuropsychologyCognitionGeneral MedicineMiddle Agedkognitiiviset prosessitMental Status and Dementia TestsStrokeNeuropsychology and Physiological PsychologyNeurologyvalidointiFemaleRC321-571Research ArticleAdultmedicine.medical_specialtyPsychometricsArticle SubjecttoimintahäiriötConcurrent validityNeurosciences. Biological psychiatry. NeuropsychiatrySensitivity and Specificity03 medical and health sciencesCronbach's alphaHumansCognitive DysfunctionAgedseulontatutkimusReceiver operating characteristicbusiness.industryReproducibility of Resultsstroke patientsmedicine.diseasecognitive screening methodROC CurvePhysical therapyNeurology (clinical)Cognition Disordersbusiness030217 neurology & neurosurgeryBehavioural Neurology
researchProduct

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results…

2009

Background Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association between cognitive impairment and magnetic resonance imaging (MRI) disease measures in patients with relapsing–remitting (RR) MS is unclear. Objectives To study the prevalence of cognitive impairment and its relation with MRI disease measures in mildly disabled patients with RRMS. Methods Patients aged 18–50 years with RRMS (McDonald criteria) and an Expanded Disability Status Scale (EDSS) score ≤4.0, who were enrolled in the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study, underwent baseline standardized MRI complete neurological examination and neuropsychological testing. Results…

MalePediatricsIntelligenceRelapsing-RemittingNeuropsychological TestsSeverity of Illness IndexDisability EvaluationCognitionRisk FactorsOdds RatioPrevalenceNeuropsychological assessmentProspective StudiesNeurologic Examinationmedicine.diagnostic_testCognitive impairmet. Cognitive function. Multiple Sclerosis. Neuropsychological assessment.Cognitive disorderNeuropsychologyAge FactorsMiddle AgedMagnetic Resonance ImagingCognitive testTreatment OutcomeNeurologyItalyFemaleSettore MED/26 - NeurologiaPsychologyAdultmedicine.medical_specialtyMultiple SclerosisAdolescentNeurological examinationRisk AssessmentYoung AdultMultiple Sclerosis Relapsing-RemittingPredictive Value of TestsMagnetic Resonance Imaging; Young Adult; Age Factors; Odds Ratio; Immunologic Factors; Humans; Multiple Sclerosis Relapsing-Remitting; Cognition; Italy; Risk Assessment; Adult; Treatment Outcome; Adolescent; Neuropsychological Tests; Male; Severity of Illness Index; Neurologic Examination; Interferon-beta; Predictive Value of Tests; Cognition Disorders; Cross-Sectional Studies; Intelligence; Prospective Studies; Risk Factors; Disability Evaluation; Middle Aged; Female; PrevalencemedicineHumansImmunologic FactorsExpanded Disability Status ScaleMultiple sclerosisMcDonald criteriaInterferon-betamedicine.diseaseCross-Sectional StudiesPhysical therapyNeurology (clinical)Cognition Disorders
researchProduct

Neurocognitive functioning in children with type-1 diabetes with and without episodes of severe hypoglycaemia

2007

Previous studies have shown that recurrent severe hypoglycaemia can cause long-term cognitive impairment in children with type-1 diabetes, but the results are controversial, possibly due to the heterogeneity of samples and lack of comprehensive neuropsychological assessments of children. The aim of this study was to assess the effects of diabetes and severe hypoglycaemia on the neurocognitive functioning of children with a standardized, wide age-range neuropsychological test battery designed for the assessment of children. Eleven children with diabetes and a history of severe hypoglycaemia, 10 children with diabetes without a history of severe hypoglycaemia, and 10 healthy control children …

MalePediatricsmedicine.medical_specialty030209 endocrinology & metabolismNeuropsychological TestsSeverity of Illness IndexNEPSYPerceptual Disorders03 medical and health sciences0302 clinical medicineDevelopmental Neuroscience030225 pediatricsmedicineHumansNeuropsychological assessmentChildPsychiatryPsychomotor learningLanguage Disordersmedicine.diagnostic_testNeuropsychologyWechsler Adult Intelligence ScaleNeuropsychological testExecutive functionsHypoglycemia3. Good healthDiabetes Mellitus Type 1Child PreschoolPediatrics Perinatology and Child HealthFemaleNeurology (clinical)Psychomotor DisordersCognition DisordersPsychologyNeurocognitive030217 neurology & neurosurgeryDevelopmental Medicine & Child Neurology
researchProduct

Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines

2009

OBJECTIVE. Thimerosal, a mercury compound used as a preservative in vaccines administered during infancy, has been suspected to affect neuropsychological development. We compared the neuropsychological performance, 10 years after vaccination, of 2 groups of children exposed randomly to different amounts of thimerosal through immunization. METHODS. Children who were enrolled in an efficacy trial of pertussis vaccines in 1992–1993 were contacted in 2003. Two groups of children were identified, according to thimerosal content in vaccines assigned randomly in the first year of life (cumulative ethylmercury intake of 62.5 or 137.5 μg), and were compared with respect to neuropsychological outcome…

MalePediatricsmedicine.medical_specialtyTime FactorsEthylmercury compoundTime FactorDevelopmental DisabilitiesDevelopmental DisabilitieControlled trialRandomizedNeuropsychological Testslaw.inventionchemistry.chemical_compoundEthylmercurySettore MED/38 - Pediatria Generale E SpecialisticaRandomized controlled triallawHumansMedicineNeuropsychological assessmentChildVaccinesmedicine.diagnostic_testSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicabusiness.industryThimerosalPreservatives PharmaceuticalInfantThimerosalNeuropsychological testExecutive functionsBoston Naming TestchemistryPediatrics Perinatology and Child HealthImmunizationFemaleNeuropsychological TestThiomersalbusinessVaccineHuman
researchProduct

Association of placental concentrations of phenolic endocrine disrupting chemicals with cognitive functioning in preschool children from the Environm…

2020

Developmental exposure to bisphenol A (BPA) and other phenolic endocrine disrupting chemicals (EDCs) may affect child neurodevelopment, but data on the effects of prenatal exposure to phenols on cognitive function remain sparse. Our aim was to examine the association of placental concentrations of several phenolic EDCs, including BPA, parabens (PBs), and benzophenones (BzPs), with cognitive development in preschool children from the Environment and Childhood (INMA) Project in Spain. Concentrations of BPA, four PBs (methylparaben [MePB], ethylparaben [EtPB], propylparaben [PrPB], and butylparaben [BuPB]), and six BzPs (BzP-1, BzP-2, BzP-3, BzP-6, BzP-8, and 4-hydroxybenzophenone [4-OH-BzP]) …

MalePlacentaPhysiology010501 environmental sciencesEndocrine DisruptorsNeuropsychological Tests01 natural sciencesMotor function03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCognitionPhenolsPregnancyEndocrine systemMedicineHumans030212 general & internal medicineNeuropsychological assessmentCognitive skillBenzhydryl CompoundsAssociation (psychology)ChildPrenatal exposure0105 earth and related environmental sciencesGeneral Environmental ScienceButylparabenmedicine.diagnostic_testbusiness.industryConfoundingPublic Health Environmental and Occupational HealthchemistryChild PreschoolGeneral Earth and Planetary SciencesFemalebusinessClinical psychologyInternational journal of hygiene and environmental health
researchProduct

Subclinical executive function impairment in children with asymptomatic, treated phenylketonuria: A comparison with children with immunodeficiency vi…

2018

In this study we compared the neuropsychological profile of phenylketonuria (PKU) and human immunodeficiency virus (HIV) to examine the specificity of the executive function (EF) impairment reported in these two patologies. A total of 55 age-matched children and adolescents were assessed, including 11 patients with PKU, 16 patients with HIV and 28 healthy controls, underwent a neuropsychological assessment. Although neither the PKU nor the HIV group scored below the normative ranges, both groups showed lower scores in neuropsychological tests engaging EFs than controls. In addition, compared to patients with PKU the HIV group performed significantly worse in the Trail-Making Test A, Corsi S…

Malecongenital hereditary and neonatal diseases and abnormalitiesPediatricsmedicine.medical_specialtyAdolescentPhenylketonuriasprefrontal lobeCognitive NeurosciencephenylketonuriaExperimental and Cognitive PsychologyNeuropsychological TestsAsymptomatic050105 experimental psychologyDevelopmental psychologySettore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'Educazione03 medical and health sciencesExecutive Function0302 clinical medicineArts and Humanities (miscellaneous)PhenylketonuriasmedicineDevelopmental and Educational PsychologyVerbal fluency testHumans0501 psychology and cognitive sciencesNeuropsychological assessmentChildSubclinical infectionSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicamedicine.diagnostic_testWorking memory05 social sciencesNeuropsychologynutritional and metabolic diseasesHIVHIV phenylketonuria executive functions prefrontal lobe.Executive functionsexecutive functionsNeuropsychology and Physiological PsychologyFemalemedicine.symptomexecutive functions; HIV; phenylketonuria; prefrontal lobe; Adolescent; Child; Executive Function; Female; Humans; Male; Neuropsychological Tests; Phenylketonurias; Neuropsychology and Physiological Psychology; Experimental and Cognitive Psychology; Developmental and Educational Psychology; Arts and Humanities (miscellaneous); Cognitive NeurosciencePsychology030217 neurology & neurosurgery
researchProduct

Repeated assessment of the Tower of Hanoi test: reliability and age effects.

2000

The purpose of this research was to analyze the effects of repeating an executive function test. Three versions of the Tower of Hanoi (TOH) test were repeated three times each, with test-retest intervals of 2 months. Two groups of children participated in the research (7.7 and 11.6 years, n = 22 and n = 28). Repeating the assessment improved the performance and decreased the total performance time in both of the groups. The older participants improved their performance faster than the younger ones. The reliability of all the scores, besides the error scores, seemed to be satisfactory after the first few assessments. The stability of the scores was maintained through all the assessments. Th…

Malemedicine.medical_specialtyAgingAudiologyNeuropsychological TestsDevelopmental psychology03 medical and health sciences0302 clinical medicineCognitionmedicineHumansNeuropsychological assessmentApplied PsychologyReliability (statistics)medicine.diagnostic_test05 social sciencesAge Factors050301 educationReproducibility of Results030229 sport sciencesExecutive functionsTest (assessment)Clinical PsychologyFemalePsychology0503 educationTowerAssessment
researchProduct

The test accuracy of the Montreal Cognitive Assessment (MoCA) by stroke lateralisation

2017

Abstract Background The Montreal Cognitive Assessment (MoCA) is an increasingly popular screening tool for detecting cognitive impairment post-stroke. However its' test accuracy by stroke lateralisation is as yet unknown. Aim Our aim was to investigate whether the test accuracy of the MoCA differs by stroke lateralisation across different cognitive domains. Methods We retrospectively examined the cognitive profiles of 228 subacute stroke patients (86 Left, 142 Right), comparing MoCA-total and domain-specific scores with performance on detailed neuropsychological assessment. Results The prevalence of cognitive impairment detected on neuropsychological assessment was high and relatively compa…

Malemedicine.medical_specialtyNeuropsychological TestsAudiologySensitivity and SpecificityFunctional LateralityLateralization of brain functionExecutive Function03 medical and health sciencesCognition0302 clinical medicineBorderline intellectual functioningPrevalencemedicineHumansCognitive Dysfunction030212 general & internal medicineNeuropsychological assessmentPsychiatryStrokeAgedRetrospective Studiesmedicine.diagnostic_testNeuropsychologyMontreal Cognitive AssessmentCognitionMiddle Agedmedicine.diseaseExecutive functionsStrokeNeurologyFemaleNeurology (clinical)Psychology030217 neurology & neurosurgeryJournal of the Neurological Sciences
researchProduct

Underestimation of cognitive impairments by the Montreal Cognitive Assessment (MoCA) in an acute stroke unit population

2013

Abstract Background and purpose The Montreal Cognitive Assessment (MoCA) is an increasingly popular clinical screening tool for detecting cognitive impairment in stroke, but few studies have directly compared performance on the MoCA with neuropsychological assessment. Our retrospective study examined the extent to which intact performance on the MoCA reflects intact cognition as determined by neuropsychological assessment. Methods In this retrospective study, cognitive profiles for 136 acute stroke patients admitted to the Acute Stroke Unit who had available MoCA and neuropsychological assessment data were examined. Results 22% of our patients were deemed cognitively intact on the MoCA. Of …

Malemedicine.medical_specialtymedicine.medical_treatmentPopulationNeuropsychological TestsPhysical medicine and rehabilitationVisual memorymedicineHumansNeuropsychological assessmenteducationPsychiatryStrokeAgedstroke unitAged 80 and overeducation.field_of_studyRehabilitationSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicamedicine.diagnostic_testNeuropsychologyMontreal Cognitive AssessmentCognitionMiddle Agedmedicine.diseaseUnited KingdomStrokeNeurologyFemaleNeurology (clinical)Cognition DisordersPsychologyJournal of the Neurological Sciences
researchProduct

La valutazione neuropsicologica tra significatività statistica e clinica

2008

Aspetti statistici e clinici pervadono tutte le fasi della valutazione neuropsicologica, dalla scelta dei test alla loro restituzione. Il presente articolo, utilizzando i dati di due ricerche come esempio, mette in evidenza l’importanza di ognuno dei due aspetti e di come questi influenzino le diverse fasi del processo di valutazione neuropsicologica e soprattutto la decisione finale e l’eventuale intervento.

Neuropsychological assessment statistical significance clinical significance neuropsychological profiles test sensitivity
researchProduct